ERN eUROGEN is proud to be an Associate Partner of the 13th European Conference on Rare Diseases & Orphan Products (ECRD 2026), which will take place in Prague and online from 2 to 4 June 2026. It will be titled “Rare Diseases in a Changing & Competitive Europe: Shaping policies to address the unmet needs of people living with rare diseases”.
Organised by EURORDIS – Rare Diseases Europe, ECRD is the largest multi-stakeholder event for the rare disease community, bringing together patients, clinicians, researchers, policymakers, and industry representatives to shape the future of rare disease policy and practice across Europe.
The conference will begin on 2 June with a Pre-Conference Workshop focused on drafting a roadmap for the future of rare disease policy, alongside the Council of National Alliances Meeting. The main conference days will follow on 3 and 4 June 2026, featuring plenary sessions, expert tracks, and opportunities for collaboration and knowledge exchange.
Call for Poster Abstracts
Researchers, healthcare professionals, patient groups, and other stakeholders are invited to submit poster abstracts highlighting research, studies, or public health projects related to rare diseases. Full details and submission guidelines are available on the ECRD 2026 website.
Stay Updated
Public registration for ECRD 2026 will open in December 2025, when the full conference programme will also be announced. An overview of the planned tracks is already available here.
By partnering with EURORDIS on this important event, ERN eUROGEN reaffirms its commitment to advancing care, research, and collaboration for people living with rare uro-recto-genital and complex conditions.
More information is available at www.rare-diseases.eu.
